Nipah virus: pathogenesis, genome, diagnosis, and treatment

Revision as of 02:16, 7 February 2026 by Nhmkerala (talk | contribs) (Created paper page - 2026-02-07T07:46:08.721290)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Authors: Rishav Madhukalya, Urvashi Yadav, Hilal Ahmad Parray, Nisha Raj, Santhik Subhasingh Lupitha, Vivek Kumar, Anjali Saroj, Vidushi Agarwal, Dilip Kumar, Supratik Das, Rajesh Kumar

Year: 2025

Journal: Applied Microbiology and Biotechnology

DOI: 10.1007/s00253-025-13474-6

Summary

This paper is a detailed review on Nipah virus, covering its origin and spread, modes of transmission, risk factors, genome, key proteins, pathogenesis, clinical features, diagnostics, and ongoing research for therapies.

Key Findings

  • Nipah virus has high pandemic potential
  • No clinically approved antivirals, immunotherapy, or vaccines available for NiV infection
  • Discussion on different diagnostic approaches and ongoing research for NiV therapies

Methodology

  • Study Type: Review

Topics

Epidemiology, Clinical, Virology, Policy

Relevance

The paper is important for Nipah research due to its focus on pandemic preparedness, novel diagnostic and therapeutic approaches, global threat from biosafety level 4 pathogens, and animal models for NiV research.

Source

View the entire paper: File:253 2025 Article 13474.pdf